Format

Send to

Choose Destination
Diabetes. 2018 Sep;67(9):1701-1709. doi: 10.2337/dbi18-0025.

Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.

Author information

1
Naomi Berrie Diabetes Center and Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY da230@columbia.edu.

Abstract

Diabetes is caused by combined abnormalities in insulin production and action. The pathophysiology of these defects has been studied extensively and is reasonably well understood. Their causes are elusive and their manifestations pleiotropic, likely reflecting the triple threat of genes, environment, and lifestyle. Treatment, once restricted to monotherapy with secretagogues or insulin, now involves complex combinations of expensive regimens that stem the progression but do not fundamentally alter the underlying causes of the disease. As advances in our understanding of insulin action and β-cell failure reach a critical stage, here I draw on lessons learned from our research on insulin regulation of gene expression and pancreatic β-cell dedifferentiation to address the question of how we can translate this exciting biology into mechanism-based interventions to reverse the course of diabetes.

PMID:
30135131
PMCID:
PMC6110318
[Available on 2019-09-01]
DOI:
10.2337/dbi18-0025
[Indexed for MEDLINE]
Free full text

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center